Syngene Share Price Cracks 10% As Fy26 Guidance Spooks Stock Investors

Shares of Syngene International Ltd tumbled 10 per cent successful Thursday's waste and acquisition aft nan institution gave a muted gross guidance for FY26. Post Q4 results, Managing Director and CEO astatine Syngene International, Peter Bains, said gross maturation is expected to beryllium successful nan early teens that he said reflected a broad-based maturation crossed research, improvement and manufacturing services. But adjusted for inventory balancing successful ample molecule commercialized manufacturing astatine customer level, Bains expected gross maturation to beryllium only successful mid-single digits. 

Besides, CFO Deepak Jain said Ebitda separator whitethorn mean to mid-twenties and year-on-year (YoY) profit aft taxation (PAT) whitethorn spot immoderate decline. Following this, nan banal collapsed 10 per cent to deed its little circuit limit astatine Rs 675.05 connected BSE. 

For FY25, Syngene reported a gross maturation of 4 per cent and a profit autumn of 8 per cent (before objection items). After a muted first half, driven by a sectoral downturn successful US biotech funding, location was a return to maturation successful nan 2nd half of nan year, nan institution said. 

Excluding exceptional items, nan institution reported 3 per cent driblet successful Q4 profit astatine Rs 183 crore compared pinch Rs 189 crore successful nan aforesaid 4th past year. Revenue was up 11 per cent astatine Rs 1,018 crore against Rs 917 crore successful nan year-ago quarter. Ebitda separator for nan 4th fell to 35 per cent against 35.7 per cent YoY.  

"Looking astatine nan twelvemonth ahead, while nan wider world marketplace dynamics stay uncertain, we expect nan business momentum to proceed pinch pipeline build successful some mini and ample molecules, supported by caller aviator programs and conversion of existing pilots successful find services. On an underlying ground for fiscal twelvemonth 2026, we expect gross maturation successful nan early teens reflecting a broad-based maturation crossed research, improvement and manufacturing services. Adjusted for inventory balancing successful ample molecule commercialized manufacturing astatine customer level, nan reported gross maturation is apt to beryllium astatine mid-single digit," Bains said.

CFO Deepak Jain said arsenic his institution brings nan caller biologics manufacturing accommodation into operations, nan further operating costs and depreciation will effect margins. With this, he expects Ebitda separator to mean from existent levels to nan mid-twenties and year-on-year diminution successful profit aft tax. 

Syngene will beryllium hosting an investor telephone astatine 11:00 americium IST today, wherever nan elder guidance will talk nan company's capacity and reply questions from participants.

Published on: Apr 24, 2025 9:42 AM IST